Invasive pneumococcal disease: Epidemiology in children and adults prior to implementation of the conjugate vaccine in the Oxfordshire region, England

Journal of Medical Microbiology

Volumn 57, Issue 4, 2008, Pages 480-487

  Foster, Dona ^a,b   Knox, Kyle ^c   Walker, A S ^d   Griffiths, D T ^a   Moore, Hazel ^a   Haworth, Elizabeth ^b   Peto, Timothy ^d   Brueggemann, Angela B ^c   Crook, Derrick W ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b PUBLIC HEALTH ENGLAND   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PNEUMOCOCCUS POLYSACCHARIDE; PNEUMOCOCCUS VACCINE;

ADOLESCENT; ADULT; AGED; AGEISM; ARTICLE; BACTERIAL MENINGITIS; BACTERIUM ISOLATE; CASE CONTROL STUDY; CHILD; FEMALE; HUMAN; INCIDENCE; INFANT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEROTYPE; SEX RATIO; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE; UNITED KINGDOM;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; BACTEREMIA; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; ENGLAND; EPIDEMIOLOGY, MOLECULAR; FEMALE; GENOTYPE; HUMANS; INCIDENCE; INFANT; MALE; MENINGITIS, PNEUMOCOCCAL; MIDDLE AGED; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; POPULATION SURVEILLANCE; SEROTYPING; STREPTOCOCCUS PNEUMONIAE; VACCINES, CONJUGATE;

EID: 42149163390     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.47690-0     Document Type: Article

References (46)

1. Akduman, D., Ehret, J. M. & Judson, F. N. (2006). Comparison of secular trends in pneumococcal serotypes causing invasive disease in Denver, Colorado (1971-2004) and serotype coverage by marketed pneumococcal vaccines. Clin Microbiol Infect 12, 1141-1143.
2. Beall, B., McEllistrem, M., Gertz, R., Wedel, S., Boxrud, D., Gonzalez, A., Medina, M., Pai, R., Thompson, T. & other authors (2006). Pre and postvaccination clonal compositions of invasive pneumococcal serotypes for isolates collected in the United States in 1999, 2001 and 2002. J Clin Microbiol 44, 999-1017.
3. Beekmann, S. E., Heilmann, K. P., Richter, S. S., Garcia-de-Lomas, J., Doern, G. V. & The GRASP Study Group (2005). Antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis and Group A β-haemolytic streptococci in 2002-2003 results of the multinational GRASP Surveillance Program. Int J Antimicrob Agents 25, 148-156.
4. Birtles, A., McCarthy, N., Sheppard, C. L., Rutter, H., Guiver, M., Haworth, E. & George, R. C. (2005). Multilocus sequence typing directly on DNA from clinical samples and a cultured isolate to investigate linked fatal pneumococcal disease in residents of a shelter for homeless men. J Clin Microbiol 43, 2004-2008.
5. Black, S., Shinefield, H., Fireman, B., Lewis, E., Ray, P., Hansen, J., Elvin, L., Ensor, K., Hacknell, J. & other authors (2000). Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Pediatr Infect Dis J 19, 187-195.
6. Brueggemann, A. & Spratt, B. (2003). Geographic distribution and clonal diversity of Streptococcus pneumoniae serotype 1 isolates. J Clin Microbiol 41, 4966-4970.
7. Brueggemann, A., Griffiths, D., Meats, E., Peto, T., Crook, D. & Spratt, B. (2003). Clonal relationships between invasive and carriage Streptococcus pneumoniae and serotype- and clone-specific differences in invasive disease potential. J Infect Dis 187, 1424-1432.
8. Byington, C., Samore, M., Stoddard, G., Barlow, S., Daly, J., Korgenski, K., Firth, S., Glover, D., Jensen, J. & other authors (2005). Temporal trends of invasive disease due to Streptococcus pneumoniae among children in the Intermountain West: emergence of nonvaccine serogroups. Clin Infect Dis 41, 21-29.
9. CDC (2005). Outbreak of invasive pneumococcal disease - Alaska, 2003-2004. MMWR Morb Mortal Wkly Rep 54, 72-75.
10. Conaty, S., Watson, L., Dinnes, J. & Waugh, N. (2004). The effectiveness of pneumococcal polysaccharide vaccines in adults: a systematic review of observational studies and comparison with results from randomised controlled trials. Vaccine 22, 3214-3224.
11. Cutts, F., Zaman, S., Enwere, G., Jaffar, S., Levine, O., Okoko, J., Oluwalana, C., Vaughan, A., Obaro, S. & other authors (2005). Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial. Lancet 365, 1139-1146.
12. Dagan, R., Gradstein, S., Belmaker, I., Porat, N., Siton, Y., Weber, G., Janco, J. & Yagupsky, P. (2000). An outbreak of Streptococcus pneumoniae serotype 1 in a closed community in southern Israel. Clin Infect Dis 30, 319-321.
13. Dagan, R., Givon-Lavi, N., Zamir, O. & Fraser, D. (2003). Effect of a nonavalent conjugate vaccine on carriage of antibiotic-resistant Streptococcus pneumoniae in day-care centers. Pediatr Infect Dis J 22, 532-540.
14. Dear, K., Andrews, R., Holden, J. & Tatham, D. (2003). Vaccines for preventing pneumococcal infection in adults (Review). Cochrane Database Syst Rev 4, CD000422.
15. Dept Health (2006). Immunisation against Infectious Disease - "The Green Book", Chapter 25: pneumococcal.
16. Enright, M. & Spratt, B. (1998). A multilocus sequence typing scheme for Streptococcus pneumoniae: identification of clones associated with serious invasive disease. Microbiology 144, 3049-3060.
17. Fedson, D. S. & Liss, C. (2004). Precise answers to the wrong question: prospective clinical trials and the meta-analyses of pneumococcal vaccine in elderly and high-risk adults. Vaccine 22, 927-946.
18. Feikin, D. & Klugman, K. (2002). Historical changes in pneumococcal serogroup distribution: implications for the era of pneumococcal conjugate vaccines. Clin Infect Dis 35, 547-555.
19. George, R. & Melegaro, A. (2001). Invasive pneumococcal infection: England and Wales, 1999. CDR Weekly 11, 6-12.
20. Gratten, M., Morey, F., Dixon, J., Manning, K., Torzillo, P., Matters, R., Erlich, J., Hanna, J., Asche, V. & Riley, I. (1993). An outbreak of serotype 1 Streptococcus pneumoniae infection in central Australia. Med J Aust 158, 340-342.
21. Hanage, W., Huang, S., Lipsitch, M., Bishop, C., Godoy, D., Pelton, S., Goldstein, R., Huot, H. & Finkelstein, J. (2007). Diversity and antibiotic resistance among nonvaccine serotypes of Streptococcus pneumoniae carriage isolates in the post-heptavalent conjugate vaccine era. J Infect Dis 195, 347-352.
22. Hausdorff, W., Bryant, J., Paradiso, P. & Siber, G. (2000a). Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, Part 1. Clin Infect Dis 30, 100-121.
23. Hausdorff, W., Bryant, J., Kloek, C., Paradiso, P. & Siber, G. (2000b). The contribution of specific pneumococcal serogroups to different disease manisfestations: implications for conjugate vaccine formulation and use, Part II. Clin Infect Dis 30, 122-140.
24. Henriques Normark, B., Kalin, M., Ortqvist, A., Akerlund, T., Liljequist, B. O., Hedlund, J., Svenson, S. B., Zhou, J., Spratt, B. G. & other authors (2001). Dynamics of penicillin-susceptible clones in invasive pneumococcal disease J Infect Dis 184, 861-869.
25. Hoge, C. W., Reichler, M. R., Dominguez, E. A., Bremer, J. C., Mastro, T. D., Hendricks, K. A., Musher, D. M., Elliott, J. A., Facklam, R. R. & Breiman, R. F. (1994). An epidemic of pneumococcal disease in an over crowded, inadequately ventilated jail. N Engl J Med 331, 643-648.
26. HPA (2003). Invasive pneumococcal infection, England and Wales: 2000. CDR Weekly 13 (21).
27. Huang, S. S., Platt, R., Rifas-Shiman, S. L., Pelton, S. I., Goldmann, D. & Finkelstein, J. A. (2005). Post-PCV7 changes in colonizing pneumococcal serotypes in 16 Massachusetts communities, 2001 and 2004. Pediatrics 116, e408-e413.
28. Ihekweazu, C. A., Dance, D. A., Pebody, R., George, R. C., Smith, M. D., Waight, P., Christensen, H., Cartwright, K. A. & Stuart, J. M. (2007). Trends in incidence of pneumococcal disease before introduction of conjugate vaccine: South West England, 1996-2005. Epidemiol Infect, doi: 10.1017/S0950268807009715.
29. Jefferies, J. M., Johnson, C. H., Kirkham, L. A., Cowan, G. J., Ross, K. S., Smith, A., Clarke, S. C., Brueggemann, A. B., George, R. C. & other authors (2007). Presence of nonhemolytic pneumolysin in serotypes of Streptococcus pneumoniae associated with disease outbreaks. J Infect Dis 196, 936-944.
30. Kirkham, L., Jefferies, J., Kerr, A., Jing, Y., Clarke, S., Smith, A. & Mitchell, T. (2006). Identification of invasive serotype 1 streptococcal isolates that express nonhemolytic pneumolysin. J Clin Microbiol 44, 151-159.
31. Klugman, K. P., Madhi, S. A., Huebner, R. E., Kohberger, R., Mbelle, N., Pierce, N. & Vaccine Trialists Group (2003). A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection. N Engl J Med 349, 1341-1348.
32. Konradsen, H. & Kaltoft, M. (2002). Invasive pneumococcal infections in Denmark from 1995 to 1999: epidemiology, serotypes and resistance. Clin Diagn Lab Immunol 9, 358-365.
33. Lexau, C., Lynfield, R., Danila, R., Pilishvili, T., Facklam, R., Farley, M., Harrison, L., Schaffner, W., Reingold, A. & other authors (2005). Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine. JAMA 294, 2043-2051.
34. MacGowan, A. P. & Wise, R. (2005). Establishing MIC breakpoints and the interpretation of in vitro susceptibility tests. J Antimicrob Chemother 48 (Suppl. 1), 17-28.
35. Mavroidi, A., Godoy, D., Aanensen, D. M., Robinson, D. A., Hollingshead, S. K. & Spratt, B. G. (2004). Evolutionary genetics of the capsular locus of serogroup 6 pneumococci. J Bacteriol 186, 8181-8192.
36. Melegaro, A., Edmunds, W. J., Pebody, R., Miller, E. & George, R. (2006). The current burden of pneumococcal disease in England and Wales. J Infect 52, 37-48.
37. Musher, D. M., Rueda-Jaimes, A. M., Graviss, E. A. & Rodriguez-Barradas, M. C. (2006). Effect of pneumococcal vaccination: a comparison of vaccination rates in patients with bacteremic and nonbacteremic pneumococcal pneumonia. Clin Infect Dis 43, 1004-1008.
38. Noakes, K., Pebody, R. G., Gungabissoon, U., Stowe, J. & Miller, E. (2006). Pneumococcal polysaccharide vaccine uptake in England, 1989-2003, prior to the introduction of a vaccination programme for older adults. J Public Health (Oxf) 28, 242-247.
39. O'Brien, K. L., Moulton, L. H., Reid, R., Weatherholtz, R., Oski, J., Brown, L., Kumar, G., Parkinson, A., Hu, D. & other authors (2003). Efficacy and safety of seven-valent conjugate pneumococcal vaccine in American Indian children: group randomised trial. Lancet 362, 355-361.
40. Pai, R., Moore, M., Pilishvili, T., Gertz, R., Whitney, C., Beall, B. & Team, A. B. S. (2005). Postvaccine genetic structure of Streptococcus pneumoniae serotype 19A from children in the United States. J Infect Dis 192, 1988-1995.
41. Sleeman, K. L., Griffiths, D., Shackley, F., Diggle, L., Gupta, S., Maiden, M. C., Moxon, E. R., Crook, D. W. & Peto, T. E. (2006). Capsular serotype-specific attack rates and duration of carriage of Streptococcus pneumoniae in a population of children. J Infect Dis 194, 682-688.
42. Spratt, B. G., Hanage, W., Li, B., Aanensen, D. & Feil, E. (2004). Displaying the relatedness among isolates of bacterial species - the eBURST approach. FEMS Microbiol Lett 241, 129-134.
43. Whitney, C. G., Farley, M., Hadler, J., Harrison, L., Bennett, N., Lynfield, R., Reingold, A., Cieslak, P., Pilishvili, T. & other authors (2003). Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N Engl J Med 348, 1737-1746.
44. Whitney, C. G., Pilishvili, T., Farley, M. M., Schaffner, W., Craig, A. S., Lynfield, R., Nyquist, A. C., Gershman, K. A., Vazquez, M. & other authors (2006). Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case-control study. Lancet 368, 1495-1502.
45. WHO (1999). Pneumococcal vaccines; WHO position paper. Wkly Epidemiol Rec 74, 117-184.
46. WHO (2007). Pneumococcal conjugate vaccine for childhood immunization - WHO position paper. Wkly Epidemiol Rec 82, 93-104.